Detalhe da pesquisa
1.
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Ann Neurol
; 91(2): 268-281, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878197
2.
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease.
Mult Scler
; 29(14): 1736-1747, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897254
3.
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
Mult Scler
; 29(3): 363-373, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573559
4.
Silent progression in disease activity-free relapsing multiple sclerosis.
Ann Neurol
; 85(5): 653-666, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851128
5.
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.
Magn Reson Med
; 79(3): 1595-1601, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28617996
6.
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".
Ann Neurol
; 91(5): 735-736, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233827
7.
Long-term evolution of multiple sclerosis disability in the treatment era.
Ann Neurol
; 80(4): 499-510, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27464262
8.
Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
Ann Neurol
; 76(4): 568-80, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25087920
9.
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.
J Magn Reson Imaging
; 42(3): 698-708, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483607
10.
N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial.
Contemp Clin Trials
; 122: 106941, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182028
11.
Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.
J Neuroimaging
; 30(1): 110-118, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571307
12.
Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
PLoS One
; 13(11): e0208255, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496320
13.
Age, gender and normalization covariates for spinal cord gray matter and total cross-sectional areas at cervical and thoracic levels: A 2D phase sensitive inversion recovery imaging study.
PLoS One
; 10(3): e0118576, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25781178
14.
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
JAMA Neurol
; 72(8): 897-904, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26053119